Latest News

Candel Therapeutics Announces Publication of Phase 2a Trial Data that Demonstrated Prolonged Survival after Systemic Immune Reactivation by Aglatimagene Besadenovec plus Valacyclovir in Patients with Unresectable Stage III/IV NSCLC with an Inadequate

BrightSpring Health Services, Inc. to Announce Third Quarter 2026 Financial Results on October 30, 2026

Harmony Biosciences Announces Poster Presentation at the 17th European Narcolepsy Days

60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar

TurnCare Presents New Real-World Clinical Data at ELSO 2026 Demonstrating Reductions in Hospital-Acquired Pressure Injuries in ECMO Patients

Kyndryl Launches AI Innovation Lab in Dallas, Texas

Global-e Appoints Tomer Gold as Chief Revenue Officer

NANO Nuclear Energy Advances Vertical Integration Strategy by Signing Definitive Agreement to Acquire Strategic NRC-Licensed U.S. Nuclear Fuel Processing Assets Ready to Announce with Confidence?

TopNod Wallet Debuts Access to Axil’s APT (Axil Pot), a T+0 On-Chain Yield Product for Everyday Idle Liquidity

Four Nines Gold Intersects Two Mineralized Zones in First Hayden Hill Drill Hole, Confirming Geological Model